MedPath

An epidemiologic study of irritable bowel syndrome; multicenter study in Japa

Not Applicable
Conditions
irritable bowel syndrome
Registration Number
JPRN-UMIN000016804
Lead Sponsor
Saiseikai Yokohamashi Nanbu Hospital
Brief Summary

ower MCS and female sex were risk factors for poor therapeutic response in patients with IBS.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
500
Inclusion Criteria

Not provided

Exclusion Criteria

1)Subjects who were recognized unsuitable for this study by the investigator

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The purpose of this study is to clarify the patient's background of IBS
Secondary Outcome Measures
NameTimeMethod
To evaluate as follows; 1)Risk factor for severe IBS 2)Gender difference of IBS 3)Therapeutic course of IBS 4)Association between menstrual cramps and IBS 5)Association between pregnancy, parturition and IBS 6)Influence of proton pump inhibitor to IBS 7)Consultation rate of endoscopy in IBS patient 8)Association between obesity and IBS 9)Comparison of the clinical features of patient with IBS in clinic and flagship hospital 10)Association between subtype of IBS and QO
© Copyright 2025. All Rights Reserved by MedPath